InsiderTape plots every Form 4 on the price chart and flags cluster buys, CEO conviction, and first buys in years the moment they file. Start a free 7-day trial, cancel anytime.
START FREE TRIAL →John Oyler, Chief Executive Officer, is a corporate insider tracked by InsiderTape across 2 companies. The public record shows 47 open-market SEC Form 4 transactions: 0 purchases worth $0 and 47 sales worth $146.6M, reported from Aug 3, 21 to Jul 21, 26. Over this period they have been a net seller.
| Date | Company | Type | Shares | Price | Value |
|---|---|---|---|---|---|
| Jul 21, 26 | ONCBeOne Medicines Ltd. | SELL | 20.0K | $320.06 | $6.3M |
| Jul 20, 26 | ONCBeOne Medicines Ltd. | SELL | 15.5K | $318.30 | $4.8M |
| Jul 17, 26 | ONCBeOne Medicines Ltd. | SELL | 35.8K | $315.06 | $11.2M |
| Jul 16, 26 | ONCBeOne Medicines Ltd. | SELL | 42.8K | $323.59 | $13.6M |
| Jul 15, 26 | ONCBeOne Medicines Ltd. | SELL | 48.7K | $313.58 | $15.2M |
| Jul 14, 26 | ONCBeOne Medicines Ltd. | SELL | 45.9K | $307.57 | $14.1M |
| Jul 13, 26 | ONCBeOne Medicines Ltd. | SELL | 26.3K | $307.40 | $8.0M |
| Jul 10, 26 | ONCBeOne Medicines Ltd. | SELL | 5.1K | $303.03 | $1.5M |
| Jun 23, 26 | ONCBeOne Medicines Ltd. | SELL | 1.8K | $275.10 | $492K |
| Jun 16, 26 | ONCBeOne Medicines Ltd. | SELL | 1.7K | $266.69 | $455K |
| Jun 11, 26 | ONCBeOne Medicines Ltd. | SELL | 859 | $258.81 | $221K |
| Jun 8, 26 | ONCBeOne Medicines Ltd. | SELL | 3.8K | $271.14 | $1.0M |
| Dec 16, 25 | ONCBeOne Medicines Ltd. | SELL | 7.5K | $305.24 | $2.3M |
| Dec 15, 25 | ONCBeOne Medicines Ltd. | SELL | 16.3K | $314.92 | $5.1M |
| Sep 16, 25 | ONCBeOne Medicines Ltd. | SELL | 12.4K | $327.78 | $4.1M |
| Jul 9, 25 | ONCBeOne Medicines Ltd. | SELL | 10.3K | $254.83 | $2.6M |
| Jun 23, 25 | ONCBeOne Medicines Ltd. | SELL | 3.1K | $262.90 | $804K |
| Jun 17, 25 | ONCBeOne Medicines Ltd. | SELL | 1.5K | $256.49 | $374K |
| Jun 16, 25 | ONCBeOne Medicines Ltd. | SELL | 3.7K | $266.05 | $979K |
| Jun 6, 25 | ONCBeOne Medicines Ltd. | SELL | 1.4K | $255.74 | $351K |
| Mar 10, 25 | BGNEBeiGene, Ltd. | SELL | 9.3K | $246.85 | $2.3M |
| Mar 7, 25 | BGNEBeiGene, Ltd. | SELL | 13.9K | $256.10 | $3.4M |
| Mar 6, 25 | BGNEBeiGene, Ltd. | SELL | 13.6K | $264.27 | $3.5M |
| Mar 3, 25 | BGNEBeiGene, Ltd. | SELL | 19.2K | $249.25 | $4.7M |
| Oct 8, 24 | BGNEBeiGene, Ltd. | SELL | 2.8K | $236.37 | $650K |
| Jun 24, 24 | BGNEBeiGene, Ltd. | SELL | 2.4K | $160.12 | $381K |
| Jun 17, 24 | BGNEBeiGene, Ltd. | SELL | 608 | $159.91 | $97K |
| Apr 11, 24 | BGNEBeiGene, Ltd. | SELL | 5.0K | $147.74 | $732K |
| Apr 10, 24 | BGNEBeiGene, Ltd. | SELL | 12.5K | $150.85 | $1.9M |
| Apr 9, 24 | BGNEBeiGene, Ltd. | SELL | 7.9K | $154.21 | $1.2M |
| Mar 13, 24 | BGNEBeiGene, Ltd. | SELL | 6.0K | $184.17 | $1.1M |
| Mar 12, 24 | BGNEBeiGene, Ltd. | SELL | 15.5K | $169.05 | $2.5M |
| Jan 10, 23 | BGNEBeiGene, Ltd. | SELL | 2.4K | $250.26 | $605K |
| Dec 29, 22 | BGNEBeiGene, Ltd. | SELL | 1.6K | $225.13 | $365K |
| Dec 28, 22 | BGNEBeiGene, Ltd. | SELL | 367 | $224.73 | $82K |
| Dec 27, 22 | BGNEBeiGene, Ltd. | SELL | 1.1K | $224.29 | $251K |
| Nov 15, 22 | BGNEBeiGene, Ltd. | SELL | 7.6K | $210.18 | $1.6M |
| Sep 21, 22 | BGNEBeiGene, Ltd. | SELL | 2.6K | $153.12 | $394K |
| Sep 20, 22 | BGNEBeiGene, Ltd. | SELL | 9.7K | $154.77 | $1.5M |
| Sep 15, 21 | BGNEBeiGene, Ltd. | SELL | 190.2K | $383.00 | $5.6M |
| Sep 14, 21 | BGNEBeiGene, Ltd. | SELL | 157.6K | $370.48 | $4.8M |
| Sep 2, 21 | BGNEBeiGene, Ltd. | SELL | 5.6K | $332.75 | $1.8M |
| Sep 1, 21 | BGNEBeiGene, Ltd. | SELL | 127.2K | $327.50 | $3.4M |
| Aug 31, 21 | BGNEBeiGene, Ltd. | SELL | 76.8K | $307.75 | $1.8M |
| Aug 5, 21 | BGNEBeiGene, Ltd. | SELL | 34.1K | $343.48 | $880K |
| Aug 4, 21 | BGNEBeiGene, Ltd. | SELL | 49.1K | $348.12 | $3.5M |
| Aug 3, 21 | BGNEBeiGene, Ltd. | SELL | 41.4K | $341.10 | $4.1M |